Nama Insights

AGF U.S. Market Neutral Anti-Beta Fund (BTAL)

Equity Market Neutral · AGF Investments LLC · NYSE

Equity Market NeutralETF
AGF U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund in the Equity Market Neutral category. It has $301.13M in assets, an expense ratio of 1.40% and a 2.92% dividend yield. The fund will invest primarily in long positions in low beta U.S. equities and short positions in high beta U.S. equities on a dollar neutral basis, within sectors. It will construct a dollar neutral portfolio of long and short positions of U.S. equities by investing primarily in the constituent securities of the Dow Jones U.S. Thematic Market Neutral Low Beta Index in approximately the same weight as they appear in the index. The universe for the index is comprised of the top 1,000 eligible se…
Assets under management$301.13M
Expense ratio1.40%
CategoryEquity Market Neutral
Dividend yield2.92%
NAV$12.26
Fund familyAGF Investments LLC
ExchangeNYSE

Top holdings

The largest positions AGF U.S. Market Neutral Anti-Beta Fund reports, by weight.

HoldingNameWeight
MRNA Moderna Inc 1.01%
OKTA Okta Inc Class A 0.74%
ELF e.l.f. Beauty Inc 0.69%
PATH UiPath Inc Class A 0.67%
CCC CCC Intelligent Solutions Holdings Inc 0.63%
AVTR Avantor Inc 0.62%
CRL Charles River Laboratories International Inc 0.61%
GWRE Guidewire Software Inc 0.57%

Other Equity Market Neutral ETFs

TickerFundAssetsExpense
XBOX Roundhill Ultra Short Duration $286.31M 0.14%
Explore live BTAL data on Nama Insights →